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Abstract
OBJECTIVE: To master the syndrome patterns char-
acteristics and explore the effective therapy meth-
ods of Traditional Chinese Medicine (TCM) for cardi-
ac syndrome X (CSX).
METHODS: The TCM syndrome characteristics
were mastered and the TCM intervention pro-
grams were determined by clinical investigations
for TCM syndrome patterns characteristics of CSX
patients. Then, the clinical efficacy studies on TCM
intervention for CSX were carried out through ran-
domized controlled trials.
RESULTS: CSX is a clinical syndrome with the main
manifestations of chest pain and chest stuffiness,
and Qi stagnation, phlegm retention and blood sta-
sis are the basic symptoms of CSX. As a result, the
Qi-regulating, chest-relaxing and blood-activating
therapy integrated with some Western Medicines
was adopted for treatment. The effect of Qi-regulat-
ing, chest-relaxing and blood-activating therapy
can reduce the frequency and degree of angina, im-
prove the symptoms and exercise the tolerance of
patients, inhibit the inflammatory response of vas-
cular walls and protect the function of vascular en-
dothelial cells, which is better than that of the sim-
ple and conventionalWestern Medicine alone.
CONCLUSION: A good effect was achieved in the
integration of Chinese and Western Medicines for
CSX. The therapy is worthy to be applied further in
clinical practice. On the other hand, more
long-term and randomised controlled studies with
large samples are still required to further deter-
mine the clinical efficacy and safety of the therapy.
© 2013 JTCM. All rights reserved.
Key words: Microvascular angina; Qi stagnation;
Phlegm retention; Blood stasis; Regulating Qi-flow-
ing for removing blood stasis; Relieving stuffiness
of the chest-diaphragm
INTRODUCTION
Cardiac syndrome X (CSX) is a kind of clinical syn-
drome with typical symptoms of angina, positive re-
sults of electrocardiograph (ECG) and/or treadmill ex-
ercise test, negative results of coronary angiography
(CAG) and absence of coronary artery spasm, which is
also known as microvascular angina. Likoff et al 1 were
the first to report such case, referring to it as angina
pectoris with normal coronary arteries. Kemp et al 2
called it the X syndrome. CXS may be induced by vari-
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ous factors, such as the reduction of the reserve capaci-
ty of coronary artery,3 impaired endothelial function,4
estrogen deficiency,5 abnormal pain perception,6 emo-
tional factors7 and so on.
Recent studies on CSX have been increasing with the
development of percutaneous coronary intervention.
However, they focused more on a few standardised and
no exact concept such as CSX in Traditional Chinese
Medicine (TCM) has been developed. Most studies
consider that CSM belongs to the category of chest im-
pediment and chest pain. Based on the TCM theory,
we analysed the syndrome characteristics of CSX and
used the Qi-regulating, chest-relaxing and blood-acti-
vating therapy integrated with Western Medicine for
treatment.
METHODS
Analysis of the TCM syndrome patterns of CSX
A total of 12 CSX patients consisting of 5 men and 7
women aged 46 to 66 years were enrolled and investi-
gated for the TCM syndrome patterns in study I. All
patients were admitted to the Cardiovascular Depart-
ment of the First Teaching Hospital of Tianjin Univer-
sity of Chinese Medicine from March 2003 to July
2004.
The study I systematically explains the TCM pathogen-
esis characteristics of CSX. However, its analysis of the
TCM syndrome patterns of CSX was not sufficiently
clear and detailed, and the number of samples was
small. Based on these shortcomings, we summarised
the distribution characteristics of the TCM syndrome
patterns in 51 CSX patients in study II. The 51 CSX
patients consisted of 11 men and 40 women aged 35
to 71 years. All patients were admitted to the Cardio-
vascular Department of the First Teaching Hospital of
Tianjin University of Chinese Medicine from March
2003 to January 2006.
Study of Qi-regulating, chest-relaxing and
blood-activating therapy of TCM for CSX
The above studies suggest that chest pain and chest
stuffiness are the main manifestations of CSX, and Qi
stagnation, phlegm retention and blood stasis are the
most common TCM syndrome patterns. Based on the
pathogenesis characteristics of CSX, the Qi-regulating,
chest-relaxing and blood-activating therapy was deter-
mined as the main treatment method. We treated the
patients with the Qi-regulating, chest-relaxing and
blood-activating therapy integrated with some Western
Medicines and evaluated its clinical efficacy through
randomised controlled trials in study III and study IV.
The TCM syndrome patterns of 51 CSX patients were
analysed. In study III, the selected cases were assigned
to the control group (19 patients) and the treated
group (32 patients). No statistically significant differ-
ences in gender, age, main complications and distribu-
tion of risk factors were observed among the two
groups. The control group was treated with conven-
tional treatment, such as nitroglycerin injection of
5-10 mg, which is diluted by 500 mL of 5% glucose
for intravenous dripping, regulated at 20 drops/min to
30 drops/min and given once daily. When necessary,
Betaloc of 6.25-25 mg, given twice daily, and/or diltia-
zem hydrochloride of 30 mg, given trice daily, were ad-
ministered. The treated group was treated similar to
the control group aside from the herbal decoction of
the Qi-regulating, chest-relaxing and blood-activating
therapy composed of Chaihu (Radix Bupleuri) 10 g,
Zhiqiao (Fructus Aurantii) 12 g, Chuanxiong (Rhizoma
Chuanxiong) 10 g, Danggui (Radix Angelicae Sinensis)
12 g, Gualoupi (Pericarpium Trichosanthis) 15 g, Xiebai
(Bulbus Aallii Macrostemi) 10 g, Danshen (Radix Salvi-
ae Miltiorrhizae) 15 g, Yunling (Yunnan Poria) 12 g,
Chuanxiong (Rhizoma Atractylodis Macrocephalae)
12 g, Chenpi (Pericarpium Citri Reticulatae) 12 g, Hon-
ghua (Carthamus Tinctorius) 15 g, and Yanhusuo (Rhi-
zoma Corydalis) 15 g. The decoction was prepared by
decocting crude drugs with water and was boiled down
to about 300 mL and administered at 150 mL once or
twice daily. The treatment course was for 14 days.
In study IV, a total of 55 CSX patients consisting of 8
men and 47 women aged 18 to 74 years were enrolled
for the study. All patients were admitted to the Cardio-
vascular Department of the First Teaching Hospital of
Tianjin University of Chinese Medicine from July
2006 to August 2007.
The selected cases were assigned to the control group
(27 patients) and the treated group (28 patients) by the
random number table method. No statistically signifi-
cant differences in gender, age, major complications
and distribution of risk factors were observed between
the two groups. The control group was treated with
conventional treatment, such as nitroglycerin injection
of 5-10 mg, which was diluted by 500 mL of 5% glu-
cose for intravenous dripping, regulated at 20 drops/
min to 30 drops/min and given once daily. When nec-
essary, Betaloc of 6.25-12.5 mg, given twice daily, and/
or diltiazem hydrochloride of 30 mg, given thrice daily,
were administered. The treated group was treated simi-
lar to the control group aside from the herbal decoc-
tion of the Qi-regulating, chest-relaxing and blood-acti-
vating therapy composed of Chaihu (Radix Bupleuri)
10 g, Zhiqiao (Fructus Aurantii) 12 g, Gualoupi (Peri-
carpium Trichosanthis) 15 g, Chuanxiong (Rhizoma Ch-
uanxiong) 10 g, Danggui (Radix Angelicae Sinensis)
12 g, Xiebai (Bulbus Allii Macrostemi) 10 g, Danshen
(Radix Salviae Miltiorrhizae) 15 g, Yunling (Yunnan Po-
ria) 12 g, Chenpi (Pericarpium Citri Reticulatae) 12 g,
Baizhu (Rhizoma Atractylodis Macrocephalae) 12 g, Yan-
husuo (Rhzoma Corydalis) 15 g and Honghua (Cartha-
mus Tinctorius) 15 g. The decoction was prepared by
decocting crude drugs with water and boiled down to
about 300 mL. It was administered at 150 mL once or
twice daily. The treatment course was 14 days.
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RESULTS
Study I
Analysis of TCM symptoms: the main manifestations
observed in the 12 CSX patients include serious chest
pain that worsens with activity, chest stuffiness, short-
ness of breath, palpitations, swollen and dark purple
tongue with stasis spots, stringy-taut and thready
pulse, fatigue, inactive talking, irritability and red or
teeth-printed tongue in 5 patients.
Analysis of TCM pathogenesis: chest pain and stuffi-
ness, likely to be caused or aggravated when angry or
depressed, are manifestations of Qi stagnation. A dark
purple tongue with stasis spots and a stringy-taut and
thready pulse are the manifestations of blood stasis.
Based on these symptoms, the main TCM pathogene-
sis of CSX is Qi stagnation and blood stasis. Moreover,
the additional symptoms in 5 patients are manifesta-
tions of Qi and Yin deficiencies, such as mental and
physical fatigue, inactive talking, irritability and red or
teeth-printed tongue.
Study II
Analysis of TCM symptom frequency: among the 51
CSX patients, 46 had chest pain (90.2%), which is the
most common clinical manifestation of CSX. More-
over, chest stuffiness (86.3% ), abdominal distention
(70.6% ), emotional depression (60.8% ), mental and
physical fatigue (41.2% ), spontaneous perspiration
(21.6%), inactive talking (19.6%) and looking without
lustre (11.8%) were also observed (Table 1).
Analysis of tongue and pulse manifestations: among
the 51 CSX patients, 25 (49% ) had dark purple
tongue or tongue with stasis spot, 20 (39.2% ) had
greasy coating, 19 (37.3%) had a stringy-taut pulse, 9
(17.6%) had a rapid pulse and 7 (13.7%) had a weak
pulse. The analysis clearly shows that Qi stagnation,
phlegm retention and blood stasis are the primary
TCM pathogenesis of CSX.
Analysis of TCM syndrome pattern distribution: chest
pain, chest stuffiness and abdominal distention were
observed to be the most common manifestations of
CSX. Emotional depression and irritability were also
observed as main manifestations. The results suggest
that Qi stagnation, phlegm retention and blood stasis
are the primary TCM syndrome patterns. As the dis-
ease progresses, Qi and Yin deficiencies in CSX can be
observed. As shown in Table 1, 34 cases (66.7%) had
three syndrome patterns (i.e., Qi stagnation, phlegm re-
tention and blood stasis) at the same time and be-
longed to simple excess syndrome. Moreover, 17 cases
(33.3% ) also had three syndrome patterns and addi-
tional deficient syndromes, such as Qi deficiency, Yin
deficiency and both Qi and Yin deficiencies, and be-
longed to integrated deficient and excess syndrome.
Study III
Clinical efficacy on angina pectoris: in the treated
group, the clinical efficacy on angina pectoris was eval-
uated as markedly effective in 19 cases and effective in
8 cases. The total effective rate was 81.2%. In the con-
trol group, the clinical efficacy on angina pectoris was
evaluated as markedly effective in 7 cases and effective
in 3 cases. The total effective rate was 52.6%. The total
effective rate in the former was clearly better than that
in the latter (P<0.05).
Effect on the main symptoms: as shown in Table 2, the
effect on chest pain, chest stuffiness, abdominal disten-
tion, fidgetiness and palpitation in the treated group
was significantly better than that before treatment (P<
0.05 or P<0.01), whereas the improvement was only
observed in chest pain, chest stuffiness and fidgetiness
in the control group (P<0.05). The comparison be-
tween the two groups shows that the effect on chest
pain, chest stuffiness and palpitation in the treated
group is significantly better than that in the control
group (P<0.05), whereas the effect on abdominal dis-
tention and fidgetiness is insignificantly different be-
tween the two groups (P>0.05).
Table 1 Analysis of TCM symptom frequency
Symptom
Chest pain
Chest stuffiness
Abdominal distention
Emotional depression
Sticky feeling in the mouth
Mental and physical fatigue
Shortness of breath
Palpitations
Dizziness
Irritability
Anorexia
Fat body
Spontaneous perspiration
Inactive talking
Dry stool
Looking without lustre
Insomnia, dreaming and
disturbed sleep
Thin stool
Tinnitus
Dry mouth
Night sweating
Aversion to cold
Tidal fever
Forgetfulness
n
46
44
36
31
26
21
20
19
18
13
13
12
11
10
8
6
6
4
4
3
2
1
1
1
Frequency (%)
90.2
86.3
70.6
60.8
51.0
41.2
39.2
37.3
35.3
25.5
25.5
23.5
21.6
19.6
15.7
11.8
11.8
7.8
7.8
5.9
3.9
2.0
2.0
2.0
Note: TCM: Traditional Chinese Medicine.
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Effect on the TCM syndrome: according to the guid-
ing principles for clinical study on new Chinese medi-
cines, the TCM syndrome score that decreases greater
than 70% is identified as markedly effective, 30% to
70% is effective, less than 30% is ineffective and less
than 0 is aggravated. In the treated group, 15 cases
proved to be markedly effective and 12 cases were effec-
tive. The total effective rate was 84.4%. In the control
group, 6 cases proved to be markedly effective, and 5
cases were effective. The total effective rate was 57.9%.
The total effective rate in the treated group is clearly
better than that in the control group (P<0.05).
Effect on the treadmill exercise test: a treadmill exercise
test was carried out in 51 patients before treatment and
repeated after treatment in 35 patients (22 in the treat-
ed group and 13 in the control group). The results are
listed in detail in Table 3.
The result of the treadmill exercise test shows that the
maximal metabolic equivalent (Max MET) and the
time of angina onset and ST segment depression by
0.1 mV clearly improved after treatment in both groups.
However, the improvement in the treated group was bet-
ter than that in the control group (P<0.05).
Adverse reactions and drug safety: in the course of
treatment, one patient of the control group became
flustered after the sublingual administration of nitro-
glycerin, but the symptom disappeared 1 min later.
Among the treated group, 32 patients had no obvious
adverse reactions. The function tests of blood, urine,
liver and kidneys of the two groups showed no abnor-
mal changes before and after treatment.
Study IV
Clinical efficacy on angina pectoris: according to the
guiding principles for clinical study on new Chinese
medicines,11 in the treated group, the clinical efficacy
on angina pectoris in 17 cases was evaluated as marked-
ly effective and 6 cases as effective. The total effective
rate was 82.14%. In the control group, 12 cases were
evaluated as markedly effective and 3 cases as effective.
The total effective rate was 55.56%. The total effective
rate in the former is obviously better than that in the
latter (P<0.05).
Effect on the TCM syndrome: in the treated group,
the effect on TCM syndrome in 13 cases was markedly
effective and that in 11 cases was effective. The total ef-
fective rate was 82.14%. In the control group, 8 cases
were markedly effective and 7 cases were effective. The
total effective rate was 55.56%. The total effective rate
in the treated group is obviously better than that in the
control group (P<0.05).
Effect on electrocardiogram: according to the guiding
principles for clinical study on new Chinesemedicines,8
in the treated group, the effect on electrocardiogram in
7 cases was markedly effective and that in 8 cases was
effective. The total effective rate was 53.57% . In the
control group, 5 cases proved to be markedly effective,
and 8 cases were effective. The total effective rate was
48.15%. No significant difference in the total effective
rate was observed between the treated and control
groups (P>0.05).
Effect on the treadmill exercise test: a treadmill exercise
test was carried out in 55 patients before treatment and
Table 2 Effect on main symptoms ( xˉ ± s )
Symptom
Chest pain
Chest stuffiness
Abdominal distention
Fidgetiness
Palpitation
Control group (n=19)
Before treatment
2.31±0.01
2.02±0.69
1.84±0.52
1.92±0.83
1.93±0.64
After treatment
1.72±0.54a
1.54±0.61a
1.63±0.69
1.43±0.82a
1.63±0.66
Treated group (n=32)
Before treatment
2.42±0.01
2.22±0.67
1.94±0.61
2.14±0.75
1.74±0.68
After treatment
1.21±0.58bc
1.04±0.65bc
1.45±0.62a
1.67±0.55a
0.68±0.76bc
Notes: control group was treated with conventional treatment; treated group was treated similar to the control group aside from the
herbal decoction of the Qi-regulating, chest-relaxing and blood-activating therapy. aP<0.05, bP<0.01, compared with before treatment; cP<
0.05, compared with the control group after treatment.
Table 3 Effect on the treadmill exercise test ( xˉ ± s )
Item
Maximal metabolic equivalent (Mets)
Time of angina onset and ST segment
depression by 0.1 mV (s)
Control group
Before treatment
(n=19)
5.3±1.1
222.5±99.6
After treatment
(n=13)
6.0±0.8a
285.9±76.5a
Treated group
Before treatment
(n=32)
5.6±2.1
245.3±60.9
After treatment
(n=22)
7.3±1.0bc
360.7±64.8bc
Notes: control group was treated with conventional treatment; treated group was treated similar to the control group aside from the
herbal decoction of the Qi-regulating, chest-relaxing and blood-activating therapy. aP<0.05, bP<0.01, compared with before treatment;
cP<0.05, compared with the control group after treatment.
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repeated in 40 patients after treatment (18 in the treat-
ed group and 22 in the control group). The results are
listed in detail in Table 4.
The result of treadmill exercise test shows that the Max
MET, exercise duration and ST segment depression af-
ter exercise obviously improved after treatment in both
groups (P<0.05). However, the improvement in the
treated group was greater than that in the control
group (P<0.05). The result implies that the herbal de-
coction of Qi-regulating, chest-relaxing and blood-acti-
vating therapy could improve the exercise tolerance of
patients.
Effect on the endothelin-1 (ET-l), nitrogen monoxide
(NO) and hs-CRP levels: The tests of ET-l, NO and
high-sensitivity C-reactive protein(hs-CRP) levels were
carried out in 55 patients before treatment and repeat-
ed in 46 patients after treatment (25 in the treated
group and 21 in the control group). The results are list-
ed in detail in Table 5.
The test results show that the ET-l, NO and hs-CRP
levels obviously improved after treatment in both
groups (P<0.05). However, the improvement in the
treated group was greater than that in the control
group (P<0.05). The results imply that the herbal de-
coction of Qi-regulating, chest-relaxing and blood-acti-
vating therapy could inhibit the inflammatory response
of vascular walls and protect the function of vascular
endothelial cells.
Security analysis: in the course of the treatment, both
groups had no obvious adverse reactions. The func-
tion tests of blood, urine, liver, and kidneys of both
groups showed no abnormal changes before and after
treatment.
DISCUSSION
The studies (I-IV) show that CSX is a clinical syn-
drome with the main manifestations of chest pain and
chest stuffiness. The enrolled CSX cases (i.e., 19 men
and 87 women) were distributed in multiple age
groups, from 18 to 74 years old. Women are more like-
ly to be susceptible than men. Based on the TCM, the
etiology location of CSX is in the liver, the diseased
part is in the heart, and spleen dysfunction is also relat-
ed. Qi stagnation, phlegm retention and blood stasis
are considered the basic pathogenesis, and the heart
meridian blocking is the pathological result. The mani-
fested Qi stagnation, phlegm retention and blood stasis
are the basic symptoms of CSX throughout the whole
course of the disease. As a result, the Qi-regulating,
chest-relaxing and blood-activating therapy integrated
with some Western Medicine was adopted for treat-
ment. The results show that the effect of Qi-regulating,
chest-relaxing and blood-activating therapy is better
than that of the simple and conventional Western Med-
icine alone. This therapy serves to reduce the frequency
and degree of angina, improve the symptoms, and exer-
cise the tolerance of patients. Moreover, it can inhibit
the inflammatory response of vascular walls and pro-
tect the function of vascular endothelial cells.
A good effect was achieved in the integration of Chi-
nese and Western Medicine for CSX. The therapy is
worthy to be applied further in clinical practice. How-
ever, the modification of the prescription should be ap-
plied according to the individual conditions of the pa-
tients when using the Qi-regulating, chest-relaxing and
blood-activating decoction. Moreover, long-term and
Table 4 Effect on the treadmill exercise test ( xˉ ± s )
Item
Maximal metabolic equivalent (Mets)
Exercise duration (s)
ST segment depression after exercise (mm)
Control group
Before treatment
(n=27)
5.6±1.2
243.1±78.8
7.5±2.1
After treatment
(n=22)
6.2±0.7a
295.3±65.7a
6.2±1.8a
Treated group
Before treatment
(n=28)
5.9±1.8
247.8±80.8
7.9±2.4
After treatment
(n=18)
7.2±0.9ab
347.0±71.7ab
5.3±1.8ab
Notes: control group was treated with conventional treatment; treated group was treated similar to the control group aside from the herbal
decoction of the Qi-regulating, chest-relaxing and blood-activating therapy. aP<0.05, compared with the control group before treatment;
bP<0.05, compared with the control group after treatment.
Table 5 Effect on ET-l, NO and hs-CRP levels ( xˉ ± s )
Item
ET-1 (ng/L)
NO (µmol/L)
hs-CRP (mg/L)
Control group
Before treatment
(n=27)
99.64±12.61
45.41±5.91
3.47±0.24
After treatment
(n=22)
64.06±15.45a
54.69±4.62a
2.31±0.28a
Treated group
Before treatment
(n=28)
94.97±10.24
46.07±5.83
3.48±0.25
After treatment
(n=18)
50.01±13.20ab
62.34±5.60ab
1.80±0.17ab
Notes: control group was treated with conventional treatment; treated group was treated similar to the control group aside from the herbal
decoction of the Qi-regulating, chest-relaxing and blood-activating therapy. ET-l: endothelin-1; NO: nitrogen monoxide; hs-CRP:
high-sensitivity C-reactive protein. aP<0.05, compared with the control group before treatment; bP<0.05, compared with the control
group after treatment.
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randomised controlled studies with large samples are
still required to further determine the clinical efficacy
and safety of the Qi-regulating, chest-relaxing and
blood-activating therapy.
REFERENCES
1 Likoff W, Seagal BL, Kasparin H. Paradox of normal elec-
tive coronary arteriogram in patients considered to have
unmistakable coronary heart disease. N Eng J Med 1967;
276(5): 1063.
2 Kemp HG. Left ventricular function in patients with the
anginal syndrome and normal coronary arteriograms. Am
J Cardiol 1976; 32(5): 375.
3 Goel PK, Gupta SK, Agarwal A, Kapoor A. Slow coro-
nary flow: a distinct angiographic subgroup in syndrome
X. Angiology 2001; 52(8): 507-514.
4 Miatello R, Risler N, Castro C, González S, Rüttler M,
Cruzado M. Aortic smooth muscle cell proliferation and
endothelial nitric oxide synthase activity in fructose-fed
rats. Am J Hypertens 2001; 14(11):1135.
5 Peters NS, Milson I. Beneficial effect of treatment with
transdermal estradiol-17 β on exercise-induced angina and
ST segment depression in syndrome X. Int J Cardiol
2000; 64(2): 13-20.
6 Panza JA. Myocardial ischemia and the pains of the heart.
N Engl J Med 2002; 346(25): 1934-1935.
7 Asbury EA, Creed F, Collins P. Distinct psychosocial dif-
ferences between women with coronary heart disease and
cardiac syndrome X. Eur Heart J 2004; 25(19): 1695-
1701.
8 Zheng XY. Guiding principles for clinical study of new
Chinese Medicines. Beijing: China Medical Science Press,
2002: 72-73.
9 Mao JY, Zhang ZP, Wang HH, et al. Clinical analysis of
12 patients with Cardiac syndrome X. Zhong Guo Zhong
Yi Ji Zheng 2005; 14(4): 368-369.
10 Mao JY, Wang HH, Ge YB, et al. Analysis on the charac-
teristics of TCM Syndrome in 51 patients with Cardiac
Syndrome X. Zhong Yi Za Zhi 2007; 48(12): 1111-
1112.
11 Mao JY, Ge YB, Wang HH, et al. Summary of 32 patients
with cardiac syndrome X treated by TCM therapy of regu-
lating Qi, relieving chest stuffiness and promoting blood
circulation. Chin J Integr Med 2007; 13(1): 17-21.
12 Wang XL, Mao JY, Wang HH, et al. Clinical study on
Qi-regulating, chest-relaxing and blood-activating therapy
for Cardiac syndrome X. Shanghai Zhong Yi Yao 2009; 43
(1): 33-35.
199
